Relation

Articles from Blood about COVID-19 treatment interventions

  • Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

0

1

Updated 2020-11-04

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences

Related